Skip to main content
FinSpry Logo
FinSpry
GRFS logo
GRFS
(NASDAQ)
Grifols, S.A.
$7.75-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Grifols (GRFS) Stock Price & Financial Analysis

Grifols Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$7.74 - $7.83
52-Week High$10.23
52-Week Low$6.96
Open$7.78
Volume298.39K
Average Volume (3M)477.49K
Market Cap3.66B
Shares Outstanding469.40M
P/E Ratio (TTM)6.46
Forward P/E6.09
Price to Sales (P/S)0.42
Price to Book (P/B)0.39
EV/EBITDA7.35
Revenue (TTM)8.67B
Net Income (TTM)566.97M
Free Cash Flow (TTM)836.50M
EPS (TTM)$0.99
Profit Margin6.54%
Operating Margin16.23%
Return on Equity (ROE)6.11%
Debt to Equity1.14
50-Day MA$7.69
200-Day MA$8.28
52-Week Change-23.34%
Annual Dividend$0.27
Dividend Yield3.45%
Payout Ratio27.08%
Last Dividend Ex-DateJul 9, 2027

Frequently Asked Questions About Grifols

What is the current stock price for GRFS?

As of the latest trading session, GRFS stock trades at $7.75. The 52-week range is $6.96–$10.23, with a day range of $7.74–$7.83.

What is the P/E ratio for GRFS?

Grifols's trailing P/E ratio is 6.5, meaning investors pay $6.5 for every $1 of annual earnings. The forward P/E is 6.1, reflecting analyst expectations for future earnings. Grifols operates in the Healthcare sector.

Does GRFS pay dividends?

Yes, Grifols pays a 3.45% annual dividend yield ($0.27 per share). The payout ratio is 27.1%. The last ex-dividend date was 2027-07-09.

What do analysts recommend for GRFS?

Based on 1 analyst, the consensus for GRFS is Hold.

What is the market cap of GRFS?

Grifols's market capitalization is $3.64B, classifying it as a mid-cap company. Grifols operates in the Healthcare sector within the Drug Manufacturers - General industry.